stem cell therapy thailand, ivf thailand, pgd screening, stemcells,  

 

Medicare Thailand - IVF/PGD/Family planning and stem cell therapy in Bangkok, Thailand and Abroad
23rd floor, Wing Hang Finance Center
60, Gloucster Rd, Wangchai
Hong Kong
Hong Kong

PGD Screening

The PGD process-

Allowing you to know that your baby is healthy and not carrying a condition. 

Contact us now -

we will reply within 24 hours.

If you want more info we will have a specialist contact you to discuss your inquirey. 

What happens in PGD?

The biopsy

PGD requires the biopsy or removal of cells from each embryo for analysis. Our advanced embryo culture techniques allow us to wait until the embryos have reached the optimum fifth day of development when they can have a hundred or more cells, and then remove three to four at a time. Other clinics conduct the biopsy at Day 3 of the embryos' development when they consist of just six to eight cells, and only a single cell is removed, greatly reducing the number of opportunities for success.
          By waiting until embryos have reached the blastocyst stage, our scientists can select cells from the trophectoderm, the part of the embryo that will go on to form the placenta. The inner cell mass, the part that will become the baby, is not touched.
          In the diagrams at the end of this page, you can see the process illustrated.

 

The analysis

Our scientists can use a number of different methods to analyse the biopsied cells. Fluorescent in situ hybridisation (FISH) is used to count the number of certain chromosomes and to observe how they are arranged. FISH is also used to identify the sex of an embryo, as it can determine if there are two X chromosomes (usually a girl) or an X and a Y chromosome (usually a boy). If the problem is at a gene level rather than chromosome it is more common to use PCR. PCR makes millions of copies of a part of the DNA code, which allows us to see whether this part of the DNA in the sample is normal or mutant.

Interpretation

Even in the blastocyst, the embryo's cells are not in the final form they will have as a fetus and placenta after implantation. PGD for chromosome counting (preimplantation genetic 'testing' rather than true 'diagnosis') is a screening procedure that reduces the chance of Down syndrome or having a miscarriage, for example. But it does not eliminate these possibilities. So even if you have PGD, you should still have the usual first trimester screening tests you and your obstetrician would otherwise consider.

The biopsy illustrated

Embryo biopsy At Day 3 of the embryo's development, a small hole is made in the outer layer of the embryo (the "zona pellucida") using a delicate laser beam.
Embryo biopsy The embryo continues development until Day 5 or 6 when it becomes a blastocyst, characterised by the separation of cell into trophoblasts (which go on to become the placenta) and the inner cell mass (which go on to become the fetus).
Embryo biopsy Trophoblasts are drawn out through the hole using a hollow suction tube called a biopsy pipette. The required cells are separated from the others using the laser and collected separately.
Embryo biopsy

The remaining cells quickly realign and the embryo goes on developing. 


Screening for inherited disease

Preimplantation genetic diagnosis (PGD) was developed specifically for the identification of embryos with genetic abnormalities.
          These abnormalities can cause autosomal recessive diseases such as beta-thalassemia and alpha-thalassemia, autosomal dominant diseases such as many of the muscular dystrophies, and X-linked diseases such as fragile X and haemophilia.
          The gender of the embryo is always tested during PGD for an X-linked disease. It is relevant medically because the potential mother carries an abnormal gene on her X chromosome.  In these cases a genetic disease can, on average, affect half of her sons because their only X chromosome is defective.

          Couples who carry mutations for an inheritable genetic disease previously only had two options: they could either take their chances and hope that their baby would be unaffected; or they could have a prenatal test and, if foetus affected, consider terminating the pregnancy. For these couples, it might mean repeated terminations, with the associated heartache.
We have available the expertise and technology from Sydney IVF, world-renowned for its innovative work in PGD testing for inherited single gene diseases.

Sydney IVF has successfully developed tests for more than 109 conditions including the following:

  • Alagille syndrome
  • Alpers disease
  • alpha 1 anti-trypsin
  • alpha-thalassemia
  • Alport syndrome
  • anti-Kell antibodies
  • Becker muscular dystrophy
  • beta-thalassemia
  • breast cancer, gene 1
  • breast cancer, gene 2
  • carbamoyl phosphate synthetase deficiency
  • central core disease
  • cerebral arteriopathy (Cadasil)
  • Charcot-Marie-Tooth syndrome 1A
  • Charcot-Marie-Tooth syndrome 1B
  • chronic granulomatosis disease (CGD)
  • congenital adrenal hyperplasia
  • congenital disorder of glycosylation
  • congenital nephrotic syndrome
  • connexin 26
  • Crigler-Najjar syndrome I
  • Crouzon syndrome
  • cystic fibrosis
  • Czech dysplasia
  • Dejerine-Sottas syndrome
  • Duchenne muscular dystrophy
  • E-cadherin
  • early onset Alzheimer disease
  • early onset torsion dystonia
  • ectodermal dysplasia
  • Emery Dreifuss muscular dystrophy
  • epidermolysis bullosa, Herlitz junctional, gene 1
  • epidermolysis bullosa, Herlitz junctional, gene 2
  • epidermolytic palmoplantar keratosis
  • facioscapulohumeral muscular dystrophy
  • familial adenomatous polyposis
  • familial amytrophic lateral sclerosis (Lou Gehrig's disease)
  • Fechtner syndrome
  • fragile X
  • fumarase deficiency
  • galactosemia
  • Gaucher disease type 2
  • Goldberg-Shprintzen syndrome
  • Gorlin syndrome
  • haemophilia A
  • haemophilia B
  • HLA match for Wiskott-Aldrich syndrome
  • HLA match with beta thalassemia
  • HLA match with diamond blackfan anemia
  • HLA match with hyper IgM
  • HLA match with sickle cell anemia
  • HLA matching
  • Holt Oram Syndrome
  • Hunter syndrome (mucopolysaccharidosis II A)
  • Huntington disease
  • Hyper IgM
  • hypochondroplasia
  • hypophosphatasia
  • incontinentia pigmenti
  • juvenile neuronal ceroid lipofuscinosis
  • late infantile neuronal ceroid lipofuscinosis(Batten disease)
  • Lowe oculocerebrorenal syndrome
  • medium-chain acyl-CoA dehydrogenase deficiency
  • medullary thyroid carcinoma (RET)
  • metachromatic leukodystrophy
  • mucopolysaccharidosis III B
  • multiple endocrine neoplasia 2A
  • multiple hereditary exotoses
  • myotonic muscular dystrophy
  • myotubular myopathy
  • nail-patella syndrome
  • nemaline myopathy
  • nephrogenic diabetes insipidus
  • neurofibromatosis types 1
  • neurofibromatosis types 2
  • Norrie disease
  • oculocutaneous albinism
  • ornitrine transcarbamylase deficiency
  • osteogenesis imperfecta type 1
  • palmoplantar hyperkeratosis
  • Pendred syndrome
  • pericentric inversion of X
  • polycystic kidney disease, autosomal dominant, gene 1
  • polycystic kidney disease, autosomal dominant, gene 2
  • polycystic kidney disease, autosomal recessive
  • proximal myotonic myopathy
  • psoriasis, susceptibility gene
  • pulmonary alveolar proteinosis
  • retinoblastoma
  • rhesus D disease
  • Saethre-Chotzen syndrome
  • Sandhoff disease
  • sickle-cell anaemia
  • spinal muscular atrophy 1
  • spinal muscular atrophy 2
  • Stickler syndrome
  • thyroid cancer
  • transthyretin amyloidosis
  • Treacher-Collins syndrome
  • tuberous sclerosis
  • Ullrich congenital muscular dystrophy
  • vitelliform macular dystrophy
  • von Hippel-Lindau disease
  • Wilms tumour
  • Wiskott-Aldrich syndrome
  • Wolman disease
  • X-linked adrenoleukodystrophy
  • X-linked choroideremia
  • Zellweger syndrome

We can usually test for any inheritable single gene disease as long as the gene and/or mutation are known.

We can also do PGD for HLA matching, to produce an unaffected sibling who is an exact HLA match to an existing affected child. Stem cells harvested from the cord at birth may be used as a potential treatment for the affected child. www.stemcells21.com

Medicare Thailand - IVF/PGD/Family planning and stem cell therapy in Bangkok, Thailand and Abroad
23rd floor, Wing Hang Finance Center
60, Gloucster Rd, Wangchai
Hong Kong
Hong Kong